NASDAQ:AVRO AVROBIO (AVRO) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.38▼$1.4450-Day Range$1.40▼$18.2452-Week Range$0.88▼$1.65Volume206,800 shsAverage Volume269,831 shsMarket Capitalization$62.85 millionP/E Ratio2.03Dividend YieldN/APrice Target$24.00 Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Get AVROBIO alerts: Email Address Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> About AVROBIO Stock (NASDAQ:AVRO)AVROBIO, Inc., a clinical-stage gene therapy company, develops hematopoietic stem cell gene therapies to treat rare diseases in the United States. Its gene therapies employ hematopoietic stem cells that are harvested from the patient and then modified with a lentiviral vector to insert the equivalent of a functional copy of the gene that is mutated in the target disease. The company's pipeline includes AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of Gaucher disease type 1 and 3; AVR-RD-01, which is in phase 2 clinical trials for the treatment of Fabry disease; and AVR-RD-03 that is in preclinical stage for the treatment of Pompe disease. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.Read More Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> AVRO Stock News HeadlinesAugust 16, 2024 | markets.businessinsider.comBuy Rating Affirmed on Tectonic Therapeutics’ TX45 for Promising Clinical AdvancementsAugust 4, 2024 | seekingalpha.comTectonic Therapeutic: Analyzing Its Post-Merger Valuation And ProspectsSeptember 7, 2024 | Behind the Markets (Ad)⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.August 2, 2024 | investing.comTectonic Therapeutic Inc (TECX)August 1, 2024 | bizjournals.comJuly M&A deals: Eli Lilly, Desktop Metal and Eastern Bank.July 31, 2024 | uk.finance.yahoo.comGlobal Gene Therapy Strategic Research Report 2024-2030: Availability of Novel Therapies Drive Market GrowthJuly 31, 2024 | morningstar.comTectonic Therapeutic Inc TECXJuly 31, 2024 | tmcnet.comTectonic Therapeutic Announces US IND Clearance for Lead Program, TX45September 7, 2024 | Behind the Markets (Ad)⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.June 20, 2024 | investorplace.comWhy Is Avrobio (AVRO) Stock Moving Today?June 3, 2024 | businesswire.comTectonic Therapeutic Appoints Daniel Lochner as Chief Financial OfficerMay 16, 2024 | finance.yahoo.comAVROBIO, Inc. (AVRO) Stock Price, News, Quote & History - Yahoo FinanceMay 15, 2024 | fr.investing.comUn cadre d'Avrobio achète des actions d'une valeur de plus de 970 000 dollarsMay 9, 2024 | businesswire.comAVROBIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVROApril 22, 2024 | bizjournals.comDeal watch: Biopharma M&A more than doubled in Q1March 26, 2024 | wsj.comAVROBIO Inc.February 23, 2024 | ca.finance.yahoo.comAVRO Apr 2024 2.500 callFebruary 18, 2024 | finance.yahoo.comAVRO May 2024 2.500 callSee More Headlines Receive AVRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVROBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:AVRO CUSIPN/A CIK1681087 Webwww.avrobio.com Phone(617) 914-8420FaxN/AEmployees13Year FoundedN/APrice Target and Rating Average Stock Price Target$24.00 High Stock Price Target$24.00 Low Stock Price Target$24.00 Potential Upside/Downside+1,614.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$0.69 Trailing P/E Ratio2.03 Forward P/E RatioN/A P/E GrowthN/ANet Income$12.16 million Net MarginsN/A Pretax MarginN/A Return on Equity-50.52% Return on Assets-47.13% Debt Debt-to-Equity RatioN/A Current Ratio26.17 Quick Ratio26.17 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.13 per share Price / Book0.66Miscellaneous Outstanding Shares44,890,000Free Float40,764,000Market Cap$62.85 million OptionableOptionable Beta1.23 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Erik John Ostrowski M.B.A. (Age 52)President, Interim CEO, CFO & Treasurer Comp: $1.25MDr. Azadeh Golipour Ph.D. (Age 44)Chief Technology Officer Comp: $1.01MDr. Essra Ridha FFPM (Age 41)M.D., Chief Medical Officer Comp: $1.12MMr. Jeffrey Medin Ph.D.Scientific FounderMr. Steven N. Avruch J.D. (Age 62)Chief Legal Officer & Secretary Comp: $506.68kMr. Scott GottesmanVice President of Human ResourceMs. Kirsten DupuisChief of StaffMore ExecutivesKey CompetitorsFreeline TherapeuticsNASDAQ:FRLNSOPHiA GENETICSNASDAQ:SOPHCabaletta BioNASDAQ:CABAScilexNASDAQ:SCLXCompass TherapeuticsNASDAQ:CMPXView All CompetitorsInsidersBraden Michael LeonardBought 39,146 shares on 5/13/2024Total: $587,190.00 ($15.00/share)View All Insider Transactions AVRO Stock Analysis - Frequently Asked Questions How were AVROBIO's earnings last quarter? AVROBIO, Inc. (NASDAQ:AVRO) released its earnings results on Thursday, November, 4th. The company reported ($9.00) EPS for the quarter, meeting the consensus estimate of ($9.00). When did AVROBIO's stock split? AVROBIO shares reverse split before market open on Thursday, June 20th 2024. The 1-12 reverse split was announced on Thursday, June 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. When did AVROBIO IPO? AVROBIO (AVRO) raised $75 million in an initial public offering on Thursday, June 21st 2018. The company issued 4,400,000 shares at $16.00-$18.00 per share. Morgan Stanley, Cowen and Wells Fargo Securities served as the underwriters for the IPO and Wedbush Securities was co-manager. What other stocks do shareholders of AVROBIO own? Based on aggregate information from My MarketBeat watchlists, some other companies that AVROBIO investors own include Sorrento Therapeutics (SRNE), ImmunoGen (imgn), Aduro Biotech (ADRO), Aldeyra Therapeutics (ALDX), Amarin (AMRN), Biohaven (BHVN) and Nabriva Therapeutics (NBRV). This page (NASDAQ:AVRO) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVROBIO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVROBIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVRO Stock Alerts